Orabi, K. (2013) “Microbial Metabolism of Rofecoxib, A Selective COX-2 Inhibitor”, International Journal of Biotechnology for Wellness Industries, 1(4), pp. 235–240. doi: 10.6000/1927-3037.2012.01.04.3.